Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
Recruiting · NCT07271420 · Interventional (participants receive a specific treatment) · Lead sponsor: Chinese University of Hong Kong
View the official record on ClinicalTrials.gov →Interventions studied
Hydrochlorothiazide 25mg once per day
What this trial is about
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \>140 mmHg and/or DBP \>90 mmHg)
Exclusion criteria
- Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months
Where it is running
1 location listed.
- Prince of Wales Hospital. The Chinese University of Hong Kong - Hong Kong, Hong Kong